Is Berkshire Hathaway Stock a Better Buy Than an S&P 500 Index Fund?

The article argues Berkshire Hathaway may offer a better long-term risk-reward profile than an S&P 500 index fund, citing Berkshire's nearly $50 billion of expected annual net earnings and reliable cash-generating businesses. The S&P 500 trades above 20x forward earnings, with Vanguard and Goldman Sachs projecting 6%-7% average annual returns over the next decade versus its historical 10% average. However, Berkshire's $1.1 trillion size limits its ability to generate the "eye-popping" returns that characterized much of its past performance.

Analysis

The relevant distinction is factor exposure rather than “active versus passive.” BRK.B is effectively a concentrated quality/value/financials/industrials allocation with an embedded capital allocator, while SPY carries materially greater duration and megacap-AI concentration; a rotation driven by rising real yields, weaker AI monetization, or multiple compression would likely favor Berkshire on a relative basis even if absolute equity returns are muted. That said, Berkshire is not a clean defensive: its public-equity book, cyclical operating subsidiaries, and insurance underwriting exposure leave it vulnerable in a recessionary risk-off episode.

The underappreciated catalyst is not simply lower index returns but dispersion: a narrower set of attractively priced acquisition targets or market dislocations could improve Berkshire’s reinvestment opportunity set over the next 6-18 months. The counterargument is that excess liquidity can remain a drag if private-market valuations stay elevated, while succession-related multiple risk may cap upside despite resilient earnings. A relative-long thesis is falsified if AI-led earnings revisions reaccelerate and the SPY/BRK.B relative ratio breaks higher following earnings, or if Berkshire’s operating earnings and buyback cadence deteriorate materially.

Key Decisions for Investors

• Initiate a 3-6 month relative-value position: long BRK.B / short SPY, beta-adjusted, on a 2-3% rebound in broad equities. Target 8-12% relative outperformance if long-duration megacap multiples compress; exit if SPY outperforms BRK.B by 5% after the next reporting cycle.
• Use BRK.B as the preferred large-cap equity ballast versus adding to VOO/SPY where portfolios are already overexposed to NVDA-led index concentration. Size as a 2-4% allocation rather than a standalone defensive hedge, given Berkshire’s residual equity-market beta.
• Monitor Berkshire’s operating earnings, insurance combined ratio, net equity purchases, and repurchase activity at the next two quarterly reports. A decline in underwriting profitability or continued minimal deployment despite market volatility would weaken the capital-allocation upside case and argues for closing the relative trade.
• Do not initiate a directional short in NVDA solely from this valuation debate. A more actionable AI-de-rating signal would be downward hyperscaler capex guidance or a sequential deceleration in AI revenue expectations; absent that evidence, the index-concentration risk is better expressed through the BRK.B/SPY pair.